These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7862890)

  • 41. Nicotine delivery and pharmacologic response from Verve, an oral nicotine delivery product.
    Koszowski B; Viray LC; Stanfill SB; Lisko JG; Rosenberry ZR; Potts JL; Pickworth WB
    Pharmacol Biochem Behav; 2015 Sep; 136():1-6. PubMed ID: 26096037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
    Cosci F; Bertoli G; Abrams K
    Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study.
    Hajek P; Jarvis MJ; Belcher M; Sutherland G; Feyerabend C
    Psychopharmacology (Berl); 1989; 97(1):99-102. PubMed ID: 2496434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerability of concurrent use of nicotine gum and smoking in healthy volunteers.
    Stahl MM; Wohlfart B; Pahlm O
    Nicotine Tob Res; 2001 May; 3(2):157-65. PubMed ID: 11403730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study.
    Takahashi H; Fujimura Y; Hayashi M; Takano H; Kato M; Okubo Y; Kanno I; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2008 May; 11(3):413-7. PubMed ID: 17949514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Poling J; Mouratidis M; Kosten T
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):645-51. PubMed ID: 16432681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine increases chemoreflex sensitivity to hypoxia in non-smokers.
    Argacha JF; Xhaët O; Gujic M; Adamopoulos D; Beloka S; Dreyfuss C; Degaute JP; van de Borne P
    J Hypertens; 2008 Feb; 26(2):284-94. PubMed ID: 18192843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers.
    Soria R; Stapleton JM; Gilson SF; Sampson-Cone A; Henningfield JE; London ED
    Psychopharmacology (Berl); 1996 Dec; 128(3):221-6. PubMed ID: 8972541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of nicotine on electroencephalographic (EEG) and behavioural measures of visual working memory in non-smokers during a dual-task paradigm.
    Fisher DJ; Knobelsdorf A; Jaworska N; Daniels R; Knott VJ
    Pharmacol Biochem Behav; 2013 Jan; 103(3):494-500. PubMed ID: 23026057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do former smokers respond to nicotine differently from never smokers? A pilot study.
    Hughes JR; Rose GL; Callas PW
    Nicotine Tob Res; 2000 Aug; 2(3):255-62. PubMed ID: 11082826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and chronic nicotine effects on behaviour and brain activation during intertemporal decision making.
    Kobiella A; Ripke S; Kroemer NB; Vollmert C; Vollstädt-Klein S; Ulshöfer DE; Smolka MN
    Addict Biol; 2014 Sep; 19(5):918-30. PubMed ID: 23679679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroencephalographic effects of nicotine chewing gum in humans.
    Pickworth WB; Herning RI; Henningfield JE
    Pharmacol Biochem Behav; 1986 Oct; 25(4):879-82. PubMed ID: 3786346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal.
    Russell MA; Wilson C; Feyerabend C; Cole PV
    Br Med J; 1976 Aug; 2(6032):391-3. PubMed ID: 779926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of nicotine on performance, mood, and physiological parameters as related to smoking habit, gender, and suggestibility.
    Netter P; Müller MJ; Neumann A; Kamradik B
    Clin Investig; 1994 Jul; 72(7):512-8. PubMed ID: 7981579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Task-dependent effects of nicotine treatment on auditory performance in young-adult and elderly human nonsmokers.
    Sun S; Kapolowicz MR; Richardson M; Metherate R; Zeng FG
    Sci Rep; 2021 Jun; 11(1):13187. PubMed ID: 34162968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial.
    Roddy E; Romilly N; Challenger A; Lewis S; Britton J
    Tob Control; 2006 Oct; 15(5):373-6. PubMed ID: 16998171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.